News

Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE
NEXSPIKE becomes Moderna’s third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc.
US FDA approves Moderna's next-generation COVID vaccine for adults 65 or older
The U.S. Food and Drug Administration has approved Moderna's next-generation COVID-19 vaccine for everyone aged 65 and above, ...
HHS cancels funding for Moderna to develop vaccines to combat bird flu
The department cited Moderna’s use of the messenger RNA technology, which it said “remains under-tested,” for the ...
U.S. Cancels Contract With Moderna to Develop Bird Flu Vaccine
Health Secretary Robert F. Kennedy Jr. has repeatedly questioned the safety of mRNA technology, which is used in the ...
Trump administration yanks Moderna's bird flu vaccine research funding even as company reports promising test results
The Trump administration has canceled $766 million awarded to Moderna to develop a vaccine against potential pandemic ...
US cancels more than $700 million funding for Moderna bird flu vaccine
The Trump administration has canceled a contract awarded to Moderna for the late-stage development of its bird flu vaccine ...
Explore more
U.S. Ends $600M Moderna Bird Flu Vaccine Contract
THURSDAY, May 29, 2025 (HealthDay News) — The U.S. government has canceled a $600 million contract with Moderna to develop a ...
Trump administration cancels $766 million Moderna contract to fight pandemic flu
The Trump administration has canceled $766 million awarded to drugmaker Moderna Inc. to develop a vaccine against potential ...
US Cancels More $700 Million Funding for Moderna Bird Flu Vaccine
This was in addition to $176 million awarded by the U.S. Department of Health and Human Services last year to complete the ...
Moderna Announces Update on Investigational Pandemic Influenza Program
H5 avian flu vaccine study shows positive interim results Company has been notified that HHS will terminate Moderna’s award ...